Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Prognostic factors influencing decisions about surgical treatment of villoglandular adenocarcinoma of the uterine cervix.

Kim HJ, Sung JH, Lee E, Ahn S, Song SY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee JW.

Int J Gynecol Cancer. 2014 Sep;24(7):1299-305. doi: 10.1097/IGC.0000000000000197.

PMID:
24987921
2.

Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.

Poynor EA, Marshall D, Sonoda Y, Slomovitz BM, Barakat RR, Soslow RA.

Gynecol Oncol. 2006 Dec;103(3):960-5. Epub 2006 Jul 24.

PMID:
16860853
3.

Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.

Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP.

J Natl Cancer Inst. 1996 Oct 2;88(19):1361-8. Review.

4.

Well-Differentiated villoglandular adenocarcinoma of the uterine cervix: a report of 15 cases including two with lymph node metastasis.

Khunamornpong S, Maleemonkol S, Siriaunkgul S, Pantusart A.

J Med Assoc Thai. 2001 Jun;84(6):882-8.

PMID:
11556470
5.

Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.

Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, Oikawa M, Yamamoto R, Yamada H, Fujimoto S.

Acta Obstet Gynecol Scand. 2002 Dec;81(12):1144-51.

PMID:
12519111
6.

[Villoglandular adenocarcinoma of the cervix uteri. A case report and analysis of the literature].

Wiesenfeld U, Baraggino E, Melato M.

Minerva Ginecol. 1997 May;49(5):221-4. Review. Italian.

PMID:
9304084
7.

Villoglandular papillary adenocarcinoma of the uterine cervix: A report of 4 cases and a review of the literature.

Zhou QY, Chen HY, Yang SM, Li YH, Wu XQ.

Oncol Lett. 2016 Jan;11(1):837-841. Epub 2015 Nov 18.

8.

Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection.

Andersson S, Larson B, Hjerpe A, Silfverswärd C, Sällström J, Wilander E, Rylander E.

Acta Obstet Gynecol Scand. 2003 Oct;82(10):960-5.

PMID:
12956848
9.

[Study on the clinicopathologic features of 88 cases with mucinous cervical adenocarcinoma].

Zeng SY, Zhong ML, Liang MR, Li L, Jiang W, Yu XH.

Zhonghua Fu Chan Ke Za Zhi. 2013 Aug;48(8):602-6. Chinese.

PMID:
24199926
10.

Conservative Treatment Seems the Best Choice in Adenocarcinoma In Situ of the Cervix Uteri.

Baalbergen A, Molijn AC, Quint WG, Smedts F, Helmerhorst TJ.

J Low Genit Tract Dis. 2015 Jul;19(3):239-43. doi: 10.1097/LGT.0000000000000114.

PMID:
25943864
11.

Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.

Pilch H, Günzel S, Schäffer U, Tanner B, Brockerhoff P, Maeurer M, Höckel M, Hommel G, Knapstein PG.

Zentralbl Gynakol. 2001 Feb;123(2):91-101.

PMID:
11265139
12.

Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix.

Utsugi K, Shimizu Y, Akiyama F, Umezawa S, Hasumi K.

Gynecol Oncol. 2004 Jan;92(1):64-70. Review.

PMID:
14751140
13.

Early invasive adenocarcinoma of the uterine cervix: criteria for nonradical surgical treatment.

Kasamatsu T, Okada S, Tsuda H, Shiromizu K, Yamada T, Tsunematsu R, Ohmi K.

Gynecol Oncol. 2002 May;85(2):327-32.

PMID:
11972396
14.

Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.

Memarzadeh S, Natarajan S, Dandade DP, Ostrzega N, Saber PA, Busuttil A, Lentz SE, Berek JS.

Obstet Gynecol. 2003 Sep;102(3):612-9.

PMID:
12962952
15.

An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.

Look KY, Brunetto VL, Clarke-Pearson DL, Averette HE, Major FJ, Alvarez RD, Homesley HD, Zaino RJ.

Gynecol Oncol. 1996 Dec;63(3):304-11.

PMID:
8946863
16.

HPV testing in primary screening of older women.

Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P.

Br J Cancer. 1999 Oct;81(3):554-8.

17.

Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy.

Yanaranop M, Sathapornteera N, Nakrangsee S.

J Med Assoc Thai. 2014 Nov;97 Suppl 11:S87-95.

PMID:
25509701
18.

Villoglandular papillary adenocarcinoma of the uterine cervix with aggressive clinical course--a case report.

Rubesa-Mihaljević R, Vrdoljak-Mozetic D, Ostojić DV, Stemberger-Papić S, Sindik N, Krasević M.

Coll Antropol. 2010 Mar;34(1):291-4.

PMID:
20437645
19.

Villoglandular adenocarcinoma of the cervix: clarity is needed on the histological definition for this difficult diagnosis.

Macdonald RD, Kirwan J, Hayat K, Herrington CS, Shawki H.

Gynecol Oncol. 2006 Jan;100(1):192-4. Epub 2005 Nov 2.

PMID:
16266744
20.

Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay.

Berois N, De Cremoux P, Mazal D, Sica A, Cedeira M, Caserta B, Barrios E, Osinaga E, Sastre-Garau X.

Int J Gynecol Cancer. 2013 Mar;23(3):527-32. doi: 10.1097/IGC.0b013e318285e753.

PMID:
23392403
Items per page

Supplemental Content

Write to the Help Desk